Medlab Clinical Ltd
ASX:MDC
Income Statement
Earnings Waterfall
Medlab Clinical Ltd
Income Statement
Medlab Clinical Ltd
| Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
4
N/A
|
5
+7%
|
6
+17%
|
6
+11%
|
8
+26%
|
6
-22%
|
3
-52%
|
2
-34%
|
1
-61%
|
1
+10%
|
1
+60%
|
1
+11%
|
1
-36%
|
0
-61%
|
0
-96%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Gross Profit |
3
N/A
|
3
+5%
|
4
+23%
|
4
+14%
|
5
+15%
|
3
-43%
|
0
-97%
|
0
+352%
|
1
+81%
|
1
+12%
|
1
+23%
|
1
+25%
|
1
-30%
|
0
-64%
|
0
-95%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(7)
|
(7)
|
(8)
|
(10)
|
(13)
|
(14)
|
(14)
|
(13)
|
(12)
|
(10)
|
(9)
|
(10)
|
(8)
|
(5)
|
(2)
|
|
| Selling, General & Administrative |
(5)
|
(6)
|
(6)
|
(8)
|
(10)
|
(11)
|
(11)
|
(9)
|
(10)
|
(9)
|
(10)
|
(9)
|
(8)
|
(4)
|
(2)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
(1)
|
0
|
(2)
|
(3)
|
(2)
|
(1)
|
(2)
|
(2)
|
(1)
|
(0)
|
0
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
|
| Other Operating Expenses |
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(3)
|
(0)
|
0
|
2
|
1
|
3
|
2
|
1
|
0
|
(0)
|
|
| Operating Income |
(4)
N/A
|
(4)
-15%
|
(5)
-7%
|
(6)
-30%
|
(8)
-37%
|
(12)
-39%
|
(14)
-18%
|
(13)
+9%
|
(11)
+13%
|
(9)
+15%
|
(8)
+10%
|
(9)
-8%
|
(7)
+20%
|
(4)
+39%
|
(2)
+49%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Pre-Tax Income |
(4)
N/A
|
(4)
-15%
|
(5)
-8%
|
(6)
-30%
|
(8)
-32%
|
(12)
-41%
|
(13)
-17%
|
(11)
+19%
|
(10)
+12%
|
(9)
+4%
|
(8)
+10%
|
(9)
-7%
|
(6)
+28%
|
(4)
+45%
|
(2)
+40%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(4)
|
(4)
|
(5)
|
(6)
|
(8)
|
(12)
|
(13)
|
(11)
|
(10)
|
(9)
|
(8)
|
(9)
|
(6)
|
(4)
|
(2)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
|
| Net Income (Common) |
(4)
N/A
|
(4)
-15%
|
(5)
-8%
|
(6)
-31%
|
(8)
-36%
|
(12)
-43%
|
(13)
-16%
|
(12)
+14%
|
(7)
+41%
|
(5)
+33%
|
(7)
-58%
|
(9)
-25%
|
(7)
+24%
|
(4)
+42%
|
(2)
+46%
|
|
| EPS (Diluted) |
-3.11
N/A
|
-3.51
-13%
|
-3.58
-2%
|
-4.29
-20%
|
-5.81
-35%
|
-8
-38%
|
-8.9
-11%
|
-6.23
+30%
|
-3.45
+45%
|
-1.99
+42%
|
-3.13
-57%
|
-3.91
-25%
|
-2.97
+24%
|
-1.73
+42%
|
-0.93
+46%
|
|